StockData
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CARLSMED, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.66+0.25 (+1.86%)

Close on Oct 19, 2026

Market cap
$371.43M
P/E (TTM)
–
Dividend yield
–

SEC filings

17 of Carlsmed's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KSep 24, 2026Sep 30, 2026SEC EDGAR
Current report8-KSep 4, 2026Sep 8, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJun 3, 2026Jun 3, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 5, 2026SEC EDGAR
Current report8-KMay 5, 2026May 5, 2026SEC EDGAR
Proxy statementDEF 14AJun 3, 2026Apr 22, 2026SEC EDGAR
Annual report10-KDec 31, 2025Feb 25, 2026SEC EDGAR
Current report8-KFeb 25, 2026Feb 25, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Current report8-KOct 29, 2025Oct 30, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 28, 2025SEC EDGAR
Current report8-KAug 28, 2025Aug 28, 2025SEC EDGAR
Current report8-KJul 24, 2025Jul 24, 2025SEC EDGAR